Science Explorer Back to mapMap
Discussion
Company · Durham · United States

BioCryst Pharmaceuticals (United States)

biocryst.comROR OpenAlex
World rank, all time
#34,655
of 34,923
Rank in United States
#7,257
of 7,310
Research works
172
▲ 85% vs 2018-21
Citations
4.1k
24.0 per fractional work
Top-10% rate
3.6%
all institutions 10.0%
vs its own fields
0.94×
1.00× is exactly expected
Open access
31%
world 40%
International
15%
world 18%
BioCryst Pharmaceuticals (United States)

Which fields of science does BioCryst Pharmaceuticals (United States) work in?

In 2022-now, 65% of research at BioCryst Pharmaceuticals (United States) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (63%), Chemistry (13%), Biochemistry, Genetics and Molecular Biology (10%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 64.9% of its workMedicine: 14 fractional works · 62.6% of its workGenetics: 7 fractional works · 28.8% of its workHematology: 3 fractional works · 12.1% of its workInfectious Diseases: 2 fractional works · 7.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.9% of its workNephrology: 1 fractional works · 2.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.8% of its workTransplantation: 0 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.4% of its workHepatology: 0 fractional works · 1.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workRheumatology: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 2.0% of its workGeneral Health Professions: 0 fractional works · 1.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 4 fractional works · 19.0% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 9.9% of its workMolecular Biology: 2 fractional works · 9.1% of its workGenetics: 0 fractional works · 0.7% of its workImmunology and Microbiology: 2 fractional works · 9.1% of its workImmunology: 2 fractional works · 9.1% of its workPhysical Sciences: 3 fractional works · 13.8% of its workChemistry: 3 fractional works · 13.1% of its workOrganic Chemistry: 2 fractional works · 8.7% of its workSpectroscopy: 1 fractional works · 4.4% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workEngineering: 0 fractional works · 0.2% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 2.3% of its workSocial Sciences: 0 fractional works · 2.2% of its workSociology and Political Science: 0 fractional works · 2.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKBioCrystPharmaceuticals…23fractional works, 2022-now
Life Sciences19%Physical Sciences14%Health Sciences65%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine1462.6%
    2. Health Professions02.0%
    3. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology29.9%
    2. Immunology and Microbiology29.1%
    1. Chemistry313.1%
    2. Materials Science00.4%
    3. Engineering00.2%
    1. Social Sciences02.2%
    2. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.86× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 9.06× its world share, 2 worksImmunology and Micro…Chemistry: 8.35× its world share, 3 worksChemistryEngineering: 0.01× its world share, 0 worksEngineeringMaterials Science: 0.12× its world share, 0 worksMaterials ScienceHealth Professions: 0.75× its world share, 0 worksHealth ProfessionsMedicine: 3.26× its world share, 14 worksMedicineNursing: 0.74× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.17× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.1×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology9.06×2 works
  2. Chemistry8.35×3 works
  3. Medicine3.26×14 works
  4. Biochemistry, Genetics and Molecular Biology1.86×2 works
  5. Health Professions0.75×0 works
  6. Nursing0.74×0 works
  7. Social Sciences0.17×0 works
  8. Materials Science0.12×0 works
  9. Economics, Econometrics and Finance0.07×0 works
  10. Engineering0.01×0 works

Who are the top researchers at BioCryst Pharmaceuticals (United States)?

Ranked on the quality score, William P Sheridan, Yarlagadda S. Babu and Jessica M. Best lead among researchers whose main affiliation is BioCryst Pharmaceuticals (United States).

  1. 1 William P Sheridan United States · #546,988 worldwide 7k citations · 143 works
  2. 2 Yarlagadda S. Babu United States · #1,088,266 worldwide 6.5k citations · 124 works
  3. 3 Jessica M. Best United States · #1,106,689 worldwide 587 citations · 48 works
  4. 4 Heather A. Iocca United States · #1,149,874 worldwide 1.5k citations · 31 works
  5. 5 Phil Collis United States · #1,159,444 worldwide 1.8k citations · 45 works
  6. 6 Ali C. Dehghani United States · #1,257,993 worldwide 1.7k citations · 19 works
  7. 7 Amanda Mathis United States · #1,294,641 worldwide 1.3k citations · 36 works
  8. 8 Arthur J. Elliott United States · #1,638,373 worldwide 1.3k citations · 38 works
  9. 9 Melanie T. Cornpropst United States · #1,707,105 worldwide 1.4k citations · 47 works
  10. 10 Shanta Bantia United States · #2,292,294 worldwide 2.9k citations · 68 works
All ranked researchers at BioCryst Pharmaceuticals (United States)

What are the most cited papers from BioCryst Pharmaceuticals (United States)?

The most cited paper from BioCryst Pharmaceuticals (United States) is "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430" (Travis K. Warren, Jay B. Wells, Rekha G. Panchal et al., 2014), with 617 citations. Next come "BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design" (381) and "Donor heart and lung procurement: A consensus statement" (201).

Most cited papers
#PaperReleasedCitations
1 Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 Travis K. Warren, Jay B. Wells, Rekha G. Panchal et al. · Nature Open access 2 Mar 2014 617
2 BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design Yarlagadda S. Babu, Pooran Chand, Shanta Bantia et al. · Journal of Medicinal Chemistry Open access 31 Aug 2000 381
3 Donor heart and lung procurement: A consensus statement Hannah Copeland et al. · The Journal of Heart and Lung Transplantation Open access 21 Apr 2020 201
4 BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease Raymond Taylor, Pravin L. Kotian, Travis K. Warren et al. · Journal of Infection and Public Health Open access 18 Apr 2016 179
5 Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity Pooran Chand, Pravin L. Kotian, Ali C. Dehghani et al. · Journal of Medicinal Chemistry Open access 31 Oct 2001 176
All 60 most cited papers, with filters and sorting

Which keywords describe research at BioCryst Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Hereditary Angioedema, Kinin Receptor Family, Innate Immunity, Complement, Immune, Factor VIII, Hemophilia and Absolute Configuration.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Hereditary Angioedema6▲ 1428×1 topic
  2. Kinin Receptor Family6▲ 1428×1 topic
  3. Innate Immunity2▲ 26×3 topics
  4. Epidemiology2▲ 1.80×9 topics
  5. Complement2▲ 372×1 topic
  6. Immune2▲ 372×1 topic
  7. Cancer1▲ 3.9×3 topics
  8. Factor VIII1▲ 356×1 topic
  9. Hemophilia1▲ 356×1 topic
  10. Absolute Configuration1▲ 358×1 topic
  11. Amination1▲ 288×1 topic
  12. Antiretroviral Therapy1▲ 27×1 topic
  13. Catalytic1▲ 37×1 topic
  14. Chiroptical Spectroscopy1▲ 358×1 topic
  15. HIV Infection1▲ 42×1 topic
  16. Inflammation1▲ 2.1×4 topics

Which research topics does BioCryst Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Coagulation, Bradykinin, Polyphosphates, and Angioedema, Complement system in diseases, Hemophilia Treatment and Research and Synthesis and Catalytic Reactions.

Coagulation, Bradykinin,…6Coagulation, Bradykinin, Polyphosphates, and Angioedema: 6 fractional worksComplement system in diseases: 2 fractional worksHemophilia Treatment and Research: 1 fractional worksSynthesis and Catalytic Reactions: 1 fractional worksHIV/AIDS drug development and treatment: 1 fractional worksMolecular spectroscopy and chirality: 1 fractional worksBiochemical and Molecular Research: 1 fractional worksPI3K/AKT/mTOR signaling in cancer: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksRenal Diseases and Glomerulopathies: 0 fractional works
GeneticsImmunologyHematologyOrganic Chemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 6 works
  2. 2 Complement system in diseases Immunology 2 works
  3. 3 Hemophilia Treatment and Research Hematology 1 works
  4. 4 Synthesis and Catalytic Reactions Organic Chemistry 1 works
  5. 5 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  6. 6 Molecular spectroscopy and chirality Spectroscopy 1 works
  7. 7 Biochemical and Molecular Research Molecular Biology 1 works
  8. 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  9. 9 Chronic Myeloid Leukemia Treatments Hematology 1 works
  10. 10 Renal Diseases and Glomerulopathies Nephrology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.3%not open68.7%

World: 40% of research is openly available.

with international co-authors14.6%domestic only85.4%

World: 18% is written across borders.

How has BioCryst Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 85% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioCryst Pharmaceuticals (United States) as a percentage of every work published that year, 0.000072% in 2024.

still counting0.00050%0.0010%0.0015%BioCryst Pharmaceuticals (United States)0.000097% in 2025200020102020

Fractional works of BioCryst Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Durham

All research institutions in Durham

Share BioCryst Pharmaceuticals (United States)'s ranking

BioCryst Pharmaceuticals (United States) on Science Explorer

A card with BioCryst Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioCryst Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.